Senate Democrats are poised to pass a reconciliation bill next week that would, among other things, allow the federal government to "negotiate" prescription drug prices and more.
Sally C. Pipes, president and CEO of the Pacific Research Institute, spoke on the bill's impact and how it will affect inflation and the future of drug development. Sally has recently published op-eds on how the reconciliation package will undermine drug research in the likes of the Washington Examiner, Newsmax, and the Pittsburgh Post-Gazette. Find her article here.
HR 1 Rush To Reason October 30 2020 by John Rush
HR 1 Rush To Reason February 16 2021 by John Rush
Is China playing by the rules — or gaming the system? In this episode of Rush to Reason, John Rush and Andy Peth are...